Elicio Therapeutics Inc (ELTX)
10.01
+0.63
(+6.72%)
USD |
NASDAQ |
May 17, 16:00
10.01
0.00 (0.00%)
Pre-Market: 20:00
Elicio Therapeutics Price to Book Value: 9.032 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 9.032 |
| May 16, 2024 | 8.430 |
| May 15, 2024 | 9.347 |
| May 14, 2024 | 9.257 |
| May 13, 2024 | 8.672 |
| May 10, 2024 | 8.457 |
| May 09, 2024 | 8.538 |
| May 08, 2024 | 8.403 |
| May 07, 2024 | 8.133 |
| May 06, 2024 | 8.070 |
| May 03, 2024 | 8.070 |
| May 02, 2024 | 8.088 |
| May 01, 2024 | 7.954 |
| April 30, 2024 | 8.268 |
| April 29, 2024 | 8.178 |
| April 26, 2024 | 8.079 |
| April 25, 2024 | 8.178 |
| April 24, 2024 | 8.313 |
| April 23, 2024 | 8.286 |
| April 22, 2024 | 8.753 |
| April 19, 2024 | 7.549 |
| April 18, 2024 | 7.396 |
| April 17, 2024 | 8.358 |
| April 16, 2024 | 8.655 |
| April 15, 2024 | 8.295 |
| Date | Value |
|---|---|
| April 12, 2024 | 8.852 |
| April 11, 2024 | 8.888 |
| April 10, 2024 | 7.882 |
| April 09, 2024 | 7.909 |
| April 08, 2024 | 7.783 |
| April 05, 2024 | 7.954 |
| April 04, 2024 | 6.758 |
| April 03, 2024 | 6.624 |
| April 02, 2024 | 6.668 |
| April 01, 2024 | 6.399 |
| March 28, 2024 | 6.830 |
| March 27, 2024 | 6.704 |
| March 26, 2024 | 6.381 |
| March 25, 2024 | 6.201 |
| March 22, 2024 | 6.129 |
| March 21, 2024 | 5.932 |
| March 20, 2024 | 5.932 |
| March 19, 2024 | 5.725 |
| March 18, 2024 | 5.752 |
| March 15, 2024 | 4.222 |
| March 14, 2024 | 4.425 |
| March 13, 2024 | 4.307 |
| March 12, 2024 | 4.628 |
| March 11, 2024 | 4.636 |
| March 08, 2024 | 4.155 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.763
Minimum
Sep 15 2023
9.347
Maximum
May 15 2024
4.599
Average
3.873
Median
Nov 27 2023
Price to Book Value Benchmarks
| Immuneering Corp | 0.5537 |
| Outlook Therapeutics Inc | -- |
| Amylyx Pharmaceuticals Inc | 0.3836 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
Price to Book Value Related Metrics
| Price | 10.01 |
| Earnings Yield | -254.6% |
| Market Cap | 102.72M |